Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange

doi:10.1016/S0140-6736(15)60294-X

Scientific article

English

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Published inLancet, vol. 386, no. 9998, p. 1049-1056

Publication date2015

Abstract

One of the standard options in the treatment of stage IIIA/N2 non-small-cell lung cancer is neoadjuvant chemotherapy and surgery. We did a randomised trial to investigate whether the addition of neoadjuvant radiotherapy improves outcomes.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Groupe Roth Arnaud (oncologie) (285)

Citation (ISO format)

PLESS, Miklos et al. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. In: Lancet, 2015, vol. 386, n° 9998, p. 1049–1056. doi: 10.1016/S0140-6736(15)60294-X

Article (Published version)

Identifiers

PID : unige:75842
DOI : 10.1016/S0140-6736(15)60294-X
PMID : 26275735

Journal ISSN0140-6736

635views

0downloads

Creation18/08/2015 15:36:00

First validation18/08/2015 15:36:00

Update14/03/2023 23:40:43

Status update14/03/2023 23:40:42

Last indexation31/10/2024 01:28:24

Archive ouverte UNIGE

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

One of the standard options in the treatment of stage IIIA/N2 non-small-cell lung cancer is neoadjuvant chemotherapy and surgery. We did a randomised trial to investigate whether the addition of neoadjuvant radiotherapy improves outcomes.

Technical informations